» Articles » PMID: 11672464

Risk Factors for Toxoplasmic Encephalitis in HIV-infected Patients: a Case-control Study in Brazil

Overview
Date 2001 Oct 24
PMID 11672464
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A case-control study to identify the risk factors for toxoplasmic encephalitis (TE) among HIV-infected patients with latent Toxoplasma gondii infection was performed in a teaching hospital in south-eastern Brazil. Although the subjects were all positive for serum IgG antibodies to Toxoplasma, some (the cases) developed TE during routine follow-up at the hospital whereas others (the controls) did not. Adjusted odds ratios (aOR) were estimated by multiple logistic regression after controlling for potential confounders. Only 46 (22%) of the 210 cases but 93 (45%) of the 205 controls were on prophylactic regimens with co-trimoxazole [aOR = 0.30; 95% confidence interval (CI) = 0.15-0.60]. Subjects with fewer than 100 (aOR = 37.09; CI =7.49-183.67) or between 100 and 200 CD4 cells/microl (aOR = 10.20; CI =2.00-51.90) were at substantially increased risk of developing TE than those with >400 CD4 cells/microl. Although the results of preliminary, unadjusted data analysis indicated that male sex and homosexual or bisexual activity might be additional risk factors, these associations were not found to be statistically significant by multiple regression analysis. In conclusion, no risk factors for TE other than low CD4 cell counts and failure to receive prophylaxis were found among HIV-infected Brazilian patients with past exposure to Toxoplasma. Seropositive patients with CD4 cell counts above 100/microl (the point at which specific prophylaxis is usually recommended) but below 200/microl might also benefit from effective anti-TE prophylaxis.

Citing Articles

Toxoplasmic Encephalitis in an AIDS Patient with Normal CD4 Count: A Case Report.

Soleymani E, Babamahmoodi F, Davoodi L, Marofi A, Nooshirvanpour P Iran J Parasitol. 2018; 13(2):317-322.

PMID: 30069217 PMC: 6068371.


Prevalence of Toxoplasma gondii infection in HIV-infected patients and food animals and direct genotyping of T. gondii isolates, Southern Ghana.

Pappoe F, Cheng W, Wang L, Li Y, Obiri-Yeboah D, Nuvor S Parasitol Res. 2017; 116(6):1675-1685.

PMID: 28434050 DOI: 10.1007/s00436-017-5442-x.


Latent Toxoplasma gondii Infection and Associated Risk Factors among HIV-Infected Individuals at Arba Minch Hospital, South Ethiopia.

Yohanes T, Debalke S, Zemene E AIDS Res Treat. 2014; 2014:652941.

PMID: 25431660 PMC: 4241326. DOI: 10.1155/2014/652941.


Toxoplasma encephalitis in HIV/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional study.

Namme Luma H, Tchaleu B, Mapoure Y, Temfack E, Doualla M, Halle M BMC Res Notes. 2013; 6:146.

PMID: 23587093 PMC: 3636036. DOI: 10.1186/1756-0500-6-146.


Toxoplasma gondii and the blood-brain barrier.

Feustel S, Meissner M, Liesenfeld O Virulence. 2012; 3(2):182-92.

PMID: 22460645 PMC: 3396697. DOI: 10.4161/viru.19004.